Seenu Hariprasad to Aged, 80 and over
This is a "connection" page, showing publications Seenu Hariprasad has written about Aged, 80 and over.
Connection Strength
0.496
-
Reassessment of Scleral Depression in the Clinical Setting. Ophthalmology. 2015 Nov; 122(11):2360-1.
Score: 0.062
-
Outcomes of chronic macular hole surgical repair. Indian J Ophthalmol. 2014 Jul; 62(7):795-8.
Score: 0.058
-
Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am J Ophthalmol. 2013 Jun; 155(6):1038-1044.e2.
Score: 0.053
-
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol. 2006 Feb; 124(2):178-82.
Score: 0.033
-
Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005 May-Jun; 36(3):258-60.
Score: 0.031
-
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol. 2005 Jan; 123(1):39-44.
Score: 0.030
-
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004 Jan; 122(1):42-7.
Score: 0.028
-
Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Trans Am Ophthalmol Soc. 2004; 102:149-55; discussion 155-7.
Score: 0.028
-
Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes. JAMA Ophthalmol. 2024 Jan 01; 142(1):53-57.
Score: 0.028
-
Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003 Mar; 121(3):345-50.
Score: 0.027
-
Vitreous penetration of orally administered gatifloxacin in humans. Trans Am Ophthalmol Soc. 2002; 100:153-9.
Score: 0.025
-
Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):238-44.
Score: 0.016
-
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration. J Ocul Pharmacol Ther. 2012 Dec; 28(6):581-8.
Score: 0.013
-
En face spectral-domain optical coherence tomography outer retinal analysis and relation to visual acuity. Retina. 2012 Jun; 32(6):1077-86.
Score: 0.013
-
Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. Retina. 2010 Nov-Dec; 30(10):1573-8.
Score: 0.011
-
Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm. 2011 Feb; 19(1):32-8.
Score: 0.011
-
A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. Ophthalmology. 2009 Nov; 116(11):2141-8.e1.
Score: 0.010
-
Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment. Trans Am Ophthalmol Soc. 2006; 104:196-201.
Score: 0.008
-
Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol. 1999 May; 127(5):516-22.
Score: 0.005
-
Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998 Feb; 39(2):385-90.
Score: 0.005